Trials / Conditions / Antiphospholipid Syndrome (APS)

Antiphospholipid Syndrome (APS)

15 registered clinical trials studyying Antiphospholipid Syndrome (APS) — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases NCT07439029	Children's Hospital of Fudan University	Phase 1
Recruiting	Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thr NCT07372170	Infanta Leonor University Hospital	—
Not Yet Recruiting	DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study NCT06884384	Central Hospital, Nancy, France	—
Recruiting	A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases NCT07123519	China Immunotech (Beijing) Biotechnology Co., Ltd.	Phase 1
Recruiting	A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases NCT07104721	China Immunotech (Beijing) Biotechnology Co., Ltd.	Phase 1
Not Yet Recruiting	Hematological Disorders in EHPVO Patients NCT07108023	Rahab Nady	—
Not Yet Recruiting	OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs NCT06929182	Central Hospital, Nancy, France	—
Recruiting	A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647	China Immunotech (Beijing) Biotechnology Co., Ltd.	Phase 1
Enrolling By Invitation	Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) NCT06723106	Chugai Pharmaceutical	Phase 1
Recruiting	Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) NCT06371417	Chugai Pharmaceutical	Phase 1
Recruiting	Effect of Belimumab on Antibody Titers in Primary APS Patients NCT06747312	Ruijin Hospital	Phase 2
Completed	Effect of Telitacicept on Antibody Titers in Primary APS Patients NCT06315530	Ruijin Hospital	Phase 2
Recruiting	Follow-up Cohort of Patients With Antiphospholipid Syndrome NCT07178925	University Hospital, Rouen	—
Terminated	Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences Dur NCT02595346	University Hospital, Rouen	Phase 2
Active Not Recruiting	Pilot Study of Gut Commensals in Antiphospholipid Syndrome NCT01787305	Yale University	—